![]() |
Volumn 351, Issue 9114, 1998, Pages 1447-1448
|
Does neuroprotection improve stroke outcome?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 PHOSPHONOMETHYLPIPECOLIC ACID;
AMINO ACID RECEPTOR BLOCKING AGENT;
APTIGANEL;
CLOMETHIAZOLE;
GAVESTINEL;
INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY;
LUBELUZOLE;
MAGNESIUM SULFATE;
MONOCLONAL ANTIBODY;
PIRACETAM;
STREPTOKINASE;
TIRILAZAD;
TISSUE PLASMINOGEN ACTIVATOR;
UNCLASSIFIED DRUG;
BRAIN HEMORRHAGE;
CLINICAL TRIAL;
DISEASE SEVERITY;
DRUG EFFICACY;
FUNCTION TEST;
HALLUCINATION;
HUMAN;
HYPERTENSION;
INTRAVENOUS DRUG ADMINISTRATION;
META ANALYSIS;
MORTALITY;
NEUROPROTECTION;
PRIORITY JOURNAL;
PSYCHOSIS;
SHORT SURVEY;
SOMNOLENCE;
STROKE;
|
EID: 0032537392
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)78865-6 Document Type: Note |
Times cited : (53)
|
References (18)
|